Treatment of infections related to long-term venous catheters;Tratamiento de las infecciones relacionadas con catéteres venosos de larga duración

Revista Espanola de Quimioterapia

Volumn 16, Issue 3, 2003, Pages 343-360

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BURKHOLDERIA CEPACIA; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; FUNGEMIA; HUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; THROMBOPHLEBITIS;

CATHETERIZATION, CENTRAL VENOUS; EQUIPMENT CONTAMINATION; HUMANS; INFECTION; TIME FACTORS;

EID: 0345304814     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (121)

1. Goetz, A.M., Wagener, M.M., Miller, J.M., Muder, R.R. Risk of infection due to central venous catheters: Effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19: 842-845.
2. Robinson, D., Suhocki, P., Schwab, S.J. Treatment of infected tunneled venoas access hemodialysis catheters with guidewire exchange. Kidney Int 1998; 53: 1792-1794.
3. Beathard, G.A. Management of bacteremia associated with tunneled-cuffed hemodyalisis catheters. J Am Soc Nephrol 1999; 10: 1045-1049.
4. Stenqvist, O., Curelaru, I., Linder, L.E., Gustavsson, B. Stiffness of central venous catheters. Acta Anaesthesiol Scand 1983; 27: 153-157.
5. Di Costanzo, J., Sastre, B., Choux, R., Kasparian, M. Experimental approach to prevention of catheter-related central venous thrombosis. J Parenter Enteral Nutr 1988; 12: 190-194.
6. Götz, F., Peters, G. Colonization of medical devices by coagulase-negative staphylococci. En: Waldvogel, F.A., Bisno, A.L. (Eds.). Infections associated with indwelling medical devices, 3rd ed. American Society for Microbiology, Washington DC 2000; 55-88.
7. Pascual, A. Pathogenesis of catheter-related infections: Lessons for new designs. Clin Microbiol Infect 2002; 8: 256-264.
8. Sherertz, R.J., Carruth, W.A., Marosok, R.D., Espeland, M.A., Johnson, R.A., Solomon, D.D. Contribution of vascular catheter material to the pathogenesis of infection: The enhanced risk of silicone in vivo. J Biomed Mater Res 1995; 29: 635-645.
9. Diekema, D.J., Pfaller, M.A., Schmitz, F.J., Smayevsky, J., Bell, J., Jones, R.N., Beach, M and the SENTRY Participants Group. Survey of infections due to Staphylococcus species: Frequency of ocurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl. 2): S114-132.
10. Clarke, D.E., Raffin, T.A. Infections complication of indwelling long-term central venous catheters. Chest 1990; 97: 966-972.
11. Mayhall, C.G. Diagnosis and management of infections of implantable devices used for prolonged venous access. En: Remington, J.S., Swartz, M.N. (Eds.). Current clinical topics in infectious diseases. Blackwell Scientific Publications, Boston 1992; 83-110.
12. Benezra, D., Kiehn, T.E., Gold, J.M., Brown, A.E., Armstrong, D. Prospective study of infections in indwelling venous catheters using quantitative blood cultures. Am J Med 1988; 85: 495-498.
13. Raad, I.I., Hanna, H.A. Intravascular catheter-related infections. New horizons and recent advances. Arch Intern Med 2002; 162: 871-878.
14. Bouza, E., Burillo, A., Muñoz, P. Catheter-related infections: Diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8: 265-274.
15. Eggimann, P., Pittet, D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin Microbiol Infect 2002; 8: 295-309.
16. Nicastri, E., Petrosillo, N., Viale, P., Ippolito, G. Catheter-related blood-stream infections in HIV-infected patients. Ann NY Acad Sci 2001; 946: 274-290.
17. Nielsen, J., Ladefoged, S.D., Kolmos H.J.J. Dialysis catheter-related septicaemia - Focus on Staphylococcus aureus septicaemia. Nephrol Dial Transplant 1998; 13: 2847-2852.
18. Johnson, P.R., Decker, M.D., Edwards, K.M., Schaffner, W., Wright, P.F. Frequency of Broviac catheter infection in pediatric oncology patients. J Infect Dis 1986; 154: 570-578.
19. Mueller, B.U., Skelton, J., Callender, D.P.E. y cols. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992; 10: 1943-1948.
20. Jean, G., Charra, B., Chazot, C. y cols. Riskfactors analysis for long-term tunneled dialysis catheter-related bacteriemias. Nephron 2002; 91: 399-405.
21. García, E., Granier, I., Geissler, A., Boespflug, M.D., Magnan, P.E., Durand-Gasselin, J. Surgical management of Candida suppurative thrombophlebitis of superior vena cava after central venous catheterization. Intensive Care Med 1997; 23: 1002-1004.
22. Raad, I.I., Sabbagh, M.F. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: A study of 55 cases and review. Clin Infect Dis 1992; 14: 75-82.
23. Jernigan, J.A., Farr, B.M. Short-course therapy of catheter-related Staphylococcus aureas bacteremia: A meta-analysis. Ann Intern Med 1993; 119: 304-311.
24. Fowler, V.G. Jr., Li, J., Corey, G.R. y cols. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients. J Am Coll Cardiol 1997; 30: 1072-1078.
25. Lecciones, J.A., Lee, J.W., Navarro, E.E. y cols. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes. Clin Infect Dis 1992; 14: 875-883.
26. Clancy, C.J., Barchiesi, E. DiFrancesco, L.F. y cols. Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management. Eur J Clin Microbiol Infect Dis 2000; 19: 585-592.
27. Elliot, T.S.J., Moss, H.A., Tebbs, S.E. y cols. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997; 16: 210-213.
28. Livesley, M.A., Tebbs, S.E., Moss, H.A., Faroqui, M.H., Lambert, P.A., Elliott, T.S. Use of pulsed field gel electrophoresis to determine the source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1998; 17: 108-112.
29. Cooper, G.L., Schiller, A.L., Hopkins, C.C. Possible role of capillary action in pathogenesis of experimental catheter-associated dermal tunnel infections. J Clin Microbiol 1988; 26: 8-12.
30. Snydman, D.R., Pober, B.R., Murray, S.A., Gorbea, H.F., Majka, J.A., Perey, L.K. Predictive value of surveillance skin cultures in total-parenteral nutrition-related infection. Lancet 1982; 18: 1385-1388.
31. Cercenado, E., Ena, J., Rodríguez-Créixems, M., Romero, I., Bouza, E. A conservative procedure for the diagnosis of catheter-related infection. Arch Intern Med 1990; 150: 1417-1420.
32. Raad, I.I., Baba, M., Bodey, G.P. Diagnosis of catheter-related infections: The role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995; 20: 593-597.
33. Atela, I., Coll, P., Rello, J y cols. Serial surveillance cultures of skin and catheter hub specimens from critically ill patients with central venous catheters: Molecular epidemiology of infection and implications for clinical management and reseach. J Clin Microbiol 1997; 7: 1784-1790.
34. Maki, D.G., Cobb, L., Garman, J.K., Shapiro, J.M., Ringer, M., Helgerson, R.B. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial. Am J Med 1988; 85: 307-314.
35. Flowers, R.H., Schwenzer, K.J., Kopel, R.F., Fisch, M.J., Tucker, S.I., Farr, B.M. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989; 261: 878-883.
36. Mermel, L.A., McCormick, R.D., Springman, S.R., Maki, D.G. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 1991; 91 (Suppl. 3B): 197-205.
37. Maki, D.G., Stolz, S.M., Wheeler, S., Mermer, L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127: 257-266.
38. Tennenberg, S., Lieser, M., McCurdy, B. y cols. A prospective randomized trial of an antibiotic and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997; 132: 1348-1351.
39. Heard, S.O., Wagle, M., Vijayakumar, E. y cols. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158: 81-87.
40. Liñares, J., Sitges-Serra, A., Garau, J., Pérez, J.L., Martín, R. Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segment. J Clin Microbiol 1985; 21: 357-360.
41. Salzman, M.B., Isenberg, H.D., Shapiro, J.F., Lipsitz, P.J., Rubin, L.G. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993; 167: 487-490.
42. Weightman, N.C., Simpson, E.M., Speller, C.D.E., Mott, M.G., Oakhill, A. Bacteremia related to indwelling central venous catheters: Prevention, diagnosis and treatment. Eur J Clin Microbiol Infect Dis 1988; 7: 125-129.
43. De Cicco, M., Chiaradia, V., Veronesi, A. y cols. Source and route of microbial colonisation of parenteral nutrition catheters. Lancet 1989; 25: 1258-1261.
44. Rello, J., Gatell, J.M., Almirall, J., Campistol, J.M., González, J., Puig de la Bellacasa, J. Evaluation of culture techniques for identification of catheter-related infection in hemodialysis patients. Eur J Clin Microbiol Infect Dis 1989; 8: 620-622.
45. Kite, P., Dobbins, B.M., Wilcox, M.H. y cols. Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. J Clin Pathol 1997; 50: 278-282.
46. Kite, P., Dobbins, B.M., Wilcox, M.H., McMahon, M.J. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 1999; 354: 1504-1507.
47. Kristinsson, K.G., Burnett, I.A., Spencer, R.C. Evaluation of three methods for culturing long intravascular catheters. J Hosp Infect 1989; 14: 183-191.
48. Jakobsen, C.J., Hansen, V., Jensen, J.J., Grabe, N. Contamination of subclavian vein catheters: An intraluminal culture method. J Hosp Infect 1989; 13: 253-260.
49. Snydman, D.R., Murray, S.A., Kornfeld, S.J., Majka, J.A., Ellis, C.A. Total parenteral nutrition-related infections. Prospective epidemiologic study using semiquantitative methods. Am J Med 1982; 73: 695-699.
50. Tighe, M.J., Kite, P., Fawley, W.N., Thomas, D., McMahon, M.J. An endoluminal brush to detect the infected central venous catheter in situ: A pilot study. BMJ 1996; 313: 1528-1529.
51. Dittmer, I.D., Sharp, D., McNulty, C.A.M., Williams, A.J., Banks, R.A. A prospective study of central venous hemodyalisis catheter colonization and peripheral bacteremia. Clin Nephrol 1999; 51: 34-39.
52. Koch, M., Coyne, D., Hoppe-Bauer, J., Vesely, T.M. Bacterial colonization of chronic hemodialysis catheters: Evaluation with endoluminal brushes and heparin aspirate. J Vascular Access 2002; 3: 38-42.
53. Teney, J.H., Moody, M.R., Newman, K.A. y cols. Adherent miroorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med 1986; 146: 1949-1954.
54. Raad, I., Costerton, W., Sabharwal, U., Sacilowski, M., Anaissie, E., Bodey, G.P. Ultrastractural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400-407.
55. González, V., Olmos, F. Infección por catéter en UCI. Definición de términos y etiopatogenia. En: Conferencia de consenso "Infección por catéter en UCI". León Gil, C. (Ed.). SEMIUC, Férnandez Ciudad S.L., Madrid 1996; 35-44.
56. Passerini, L., Phang, P.T., Jacson, EL., Lam, K., Costerton, J.W., King, E.G. Biofilms on right heart flow-directed catheters. Chest 1987; 92: 440-446.
57. Crnich, C.J., Maki, D.G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-terms devices. Clin Infect Dis 2002; 34: 1232-1242.
58. Groeger, J.S., Lucas, A.B., Thaler, H.T. y cols. Infectious morbidity asssociated with long-term use of venous devices in patients with cancer. Ann Intern Med 1993; 119: 1168-1174.
59. Howell, P.B., Walters, P.E., Donowitiz, G.R., Farr, B.M. Riskfactors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995; 75: 1367-1375.
60. Raad, I., Davis, S., Becker, M. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993; 153: 1791-1796.
61. Sherertz, R.J., Raad, I.I., Belani, A. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28: 76-82.
62. Andrivet, P., Bacquer, A., Ngoc, C.V. y cols. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis 1994; 18: 199-206.
63. Donlan, R.M., Costerton, J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
64. Ceri, H., Olson, M.E., Stremick, C., Read, R.R., Morck, D., Buret, A. The Calgary biofilm device: New technology for rapid determination of antibiotics susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
65. Siegman-Igra, Y., Anglim, A.M., Shapiro, D.E., Adal, K.A., Strain, B.A., Farr, B.M. Diagnosis of vascular catheter-related bloodstream infection: A meta-analysis. J Clin Microbiol 1997; 35: 928-936.
66. Collington, P.J., Soni, N., Pearson, I.Y., Woods, W.P., Munro, R., Sorrell, T.C. Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol 1986; 24: 532-535.
67. Maki, D.G., Weise, C.E., Sarafin, H.W. A semiquantitative culture method for identifying intravenous-catheter-related infections. New Engl J Med 1977; 296: 1305-1309.
68. Cleri, D.J., Corrado, M.L., Seligman, S.J. Quantitative culture of intravenous catheters and other intravascular insert. J Infect Dis 1980; 141: 781-786.
69. Brunn-Bruisson, C., Abrouk, F., Legrand, P., Huet, Y., Larabi, S., Rapin, M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-877.
70. Sherertz, R.J., Heard, S.O., Raad, I.I. Diagnosis of triple-lumen catheter infection: Comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35: 641-646.
71. Cook, D., Randolph, A., Kenerman, P. y cols. Central venous catheter replacement strategies. A systematic review of the literature. Crit Care Med 1997; 25: 1417-1424.
72. Raucher, H.S., Hyatt, A.C., Barzilai, A. y cols. Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters. J Pediatr 1984; 104: 29-33.
73. Capdevila, J.A., Planes, A.M., Palomar, M. y cols. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 1992; 11: 403-407.
74. Quillice, N., Audibert, G., Conroy, M.C. y cols. Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units. Clin Infect Dis 1997; 25: 1066-1070.
75. Blot, F., Nitenberg, G., Chachaty, E. y cols. Diagnosis of catheter-related bacteraemia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354: 1071-1077.
76. Guiot, H.F.L., Helmig-Schurter, A.V., van't Noordende, J.M. The relevance of cultures of catheter-drawn blood and heparin-lock fluid to diagnose infection in hematologic patients. Ann Hematol 1992; 64: 28-34.
77. Vanhuynegem, L., Parmentier, P., Potvliege, C. In situ bacteriologic diagnosis of total parenteral nutrition catheter infection. Surgery 1988; 103: 174-177.
78. DesJardin, J.A., Falagas, M.E., Ruthazer, R. y cols. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 1999; 131: 641-647.
79. Martínez, J.A., DesJardin, J.A., Aronoff, M., Supran, S., Nasraway, S.A., Snydman, D.R. Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients. Crit Care Med 2002; 30: 7-13.
80. Guggenbichler, J.P., Berchtold, D., Allenberger, F. y cols. In vitro and in vivo effect of antibioticsw on catheter colonized by Staphylococci. Eur J Clin Microbiol Infect Dis 1992; 11: 408-415.
81. Dugdale, D.C., Ramsey, P.G. Staphylococcus aureus bacteraemia in patients with Hickman catheters. Am J Med 1990; 89: 137-141.
82. Malanoski, G.J., Samore, M.H., Pefanis, A., Karchmer, A.W. Staphylococcus aureus catheter-associated bacteremia. Arch Intern Med 1995; 155: 1161-1166.
83. Rex, J.H., Bennett, J.E., Sugar, A.M. y cols., NIAID Mycoses Study Group and the Candidemia Study Group. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 1995; 21: 994-996.
84. Nguyen, M.H., Peacock, J.E., Tanner, D.C. y cols. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155: 2429-2435.
85. Anaissie, E.J., Rex, J.H., Uzun, O., Vartivarian, S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998; 104: 238-245.
86. Kuikka, A., Valtonen, V.V. Factors associated with improved prognosis outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 1998; 17: 701-708.
87. Eltin, L.S., Bodey, G.P. Septicemia due to Xantomonas species and non-aeruginosa Pseduomonas species; increased incidence of catheter-related infections. Medicine 1990; 69: 296-306.
88. Raad, I.I., Vartivarian, S., Khan, A., Bodey, G.P. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13: 1120-1125.
89. Arnow, P.M., Quimosing, E.M., Beach, M. Consequence of intravascular catheter sepsis. Clin Infect Dis 1993; 16: 778-784.
90. Raad, I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-898.
91. Mermel, L.A., Farr, B.M., Sheretz, R.J. y cols. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272.
92. Berrington, A., Gould, F.K. Use of antibiotic locks to treat colonized central venous catheters. J Anfimicrob Chemother 2001; 48: 597-603.
93. Martínez, E., Mensa, J., Rovira, M. y cols. Central venous catheter exchange by guidewire for treatment of catheter-related bacteremia in patients undergoing BMT or intensive chemotherapy. Bone Marrow Transplant 1999; 23: 41-44.
94. Paston, M.J., Meguid, R.A., Muscaritoli, M., Forbes, B., Yang, Z.J., Meguid, M.M. Dynamics of central venous catheter-related sepsis in rats. J Clin Microbiol 1993; 31: 1652-1655.
95. Hughes, W.T., Armstrong, D., Bodey, G.P. y cols. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751.
96. García Rodríguez, J.A., Gobernado, M., Gomis, M. Guía clínica para la evaluación el tratamiento del paciente neutropénico con fiebre. Rev Esp Quiomioterap 2001; 14: 75-83.
97. Viscoli, C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 1998; 41 (Suppl. D): 65-80.
98. Wilcox, M., Winstanley, T., Spencer, R. Binding of teicoplanin and vancomycin to polymer surfaces. J Antimicrob Chemother 1994; 33: 431-441.
99. Smith, S.R., Cheesbrough, J., Spearing, R., Davies, J.M. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters. Antimicrob Agents Chemother 1989; 33: 1193-1197.
100. Van der Auwera, P., Aoun, M., Meunier, F. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised host. Antimicrob Agents Chemother 1991; 35: 451-457.
101. Menicheti, F., Martino, P., Bucaneve, G. y cols., GIMENA Infection Program. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancy. Antimicrob Agents Chemother 1994; 38: 2041-2046.
102. Rolston, K.V.I., Nguyen, H., Amos, G., Elting, L., Fainstein, V., Bodey, G.P. A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer. J Infect Dis 1994; 169: 350-355.
103. Raad, I., Bompart, F., Hachem, R. Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfoprisin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia. Eur J Clin Microbiol Infect Dis 1999; 18: 199-202.
104. Hamilton-Miller, J.M.T., Shah, S. Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: A comparison with ciprofloxacin. J Antimicrob Chemother 1997; 39 (Suppl. A): 103-108.
105. Rubinstein, E., Prokocimer, P., Talbot, G.H. Safety and tolerability of quinupristin/dalfopristin: Administration guidelines. J Antimicrob Chemother 1999; 44 (Topic A): 37-46.
106. Gander, S., Hayward, K., Finch, R. An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 2002; 49: 301-308.
107. Fowler, V.G. Jr., Li, J., Corey, G.R. y cols. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients. J Am Coll Cardiol 1997; 30: 1072-1078.
108. Rosen, A.B., Fowler, V.G. Jr., Corey, G.R. y cols. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999; 130: 810-820.
109. Jensen, A.G., Wachmann, C.H., Espersen, F., Scheibel, J., Skinhoj, P., Frimodt-Moller, N. Treatment and outcome of Staphylococcus aureus bacteremia: A prospective study of 278 cases. Arch Intern Med 2002; 162: 25-32.
110. Diekema, D.J., Jones, R.N. Oxazolidinone antibiotics. Lancet 2001; 358: 1975-1982.
111. Stevens, D.L., Herr, D., Lampiris, H., Hunt, J.L., Batts, D.H., Hafkin, B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002; 34: 1481-1490.
112. Rex, J.H., Walsh, T.J., Sobel, J.D. y cols. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662-678.
113. Raad, I.I., Bodey, G.P. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197-210.
114. Berrington, A., Gould, F.K. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 2001; 48: 597-603.
115. Longuet, P., Douard, M.C., Arlet, G., Molina, J.M., Benoit, C., Leport, C. Venous access port-related bacteremia in patients with acquired immunodefiency syndrome or cancer. The reservoir as diagnostic and therapeutic tool. Clin Infect Dis 2001; 32: 1776-1783.
116. Carratalà, J. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect 2002; 8: 282-289.
117. Randolfph, A.G., Cook, D.J., Gonzales, C.A., Andrew, M. Benefit of heparin in central venous and pulmonary artery catheters. A meta-analysis of randomized controlled trials. Chest 1998; 113: 165-171.
118. Benoit, J.L., Carandag, G., Sitrin, M., Arnow, P.M. Intraluminal antibiotic treatment of central venous catheter infections patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21: 1286-1288.
119. Vercvaigne, L.M., Sitar, D.S., Penner, B., Bernstein, K., Wang, G.Q., Burezynski, F.J. Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000; 20: 394-399.
120. Anthony, T.U., Rubin, L.G. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 1999; 43: 2074-2076.
121. Viale, P., Petrosillo, N., Signorini, L., Puoti, M., Carosi, G. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? Clin Infect Dis 2001; 33: 1947-1948.